Pharming Group Pink Sheet Forecast - 20 Period Moving Average
| PHGUF Stock | USD 0.75 0.00 0.00% |
The 20 Period Moving Average forecasted value of Pharming Group NV on the next trading day is expected to be 0.80 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.08. Pharming Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Pharming Group's historical fundamentals, such as revenue growth or operating cash flow patterns.
Pharming |
Pharming Group 20 Period Moving Average Price Forecast For the 5th of December
Given 90 days horizon, the 20 Period Moving Average forecasted value of Pharming Group NV on the next trading day is expected to be 0.80 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.08.Please note that although there have been many attempts to predict Pharming Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Pharming Group's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Pharming Group Pink Sheet Forecast Pattern
| Backtest Pharming Group | Pharming Group Price Prediction | Buy or Sell Advice |
Pharming Group Forecasted Value
In the context of forecasting Pharming Group's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Pharming Group's downside and upside margins for the forecasting period are 0.01 and 2.87, respectively. We have considered Pharming Group's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Pharming Group pink sheet data series using in forecasting. Note that when a statistical model is used to represent Pharming Group pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 74.8823 |
| Bias | Arithmetic mean of the errors | -0.0052 |
| MAD | Mean absolute deviation | 0.0263 |
| MAPE | Mean absolute percentage error | 0.0328 |
| SAE | Sum of the absolute errors | 1.0765 |
Predictive Modules for Pharming Group
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharming Group NV. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharming Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Pharming Group
For every potential investor in Pharming, whether a beginner or expert, Pharming Group's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pharming Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pharming. Basic forecasting techniques help filter out the noise by identifying Pharming Group's price trends.Pharming Group Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharming Group pink sheet to make a market-neutral strategy. Peer analysis of Pharming Group could also be used in its relative valuation, which is a method of valuing Pharming Group by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pharming Group NV Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pharming Group's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pharming Group's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Pharming Group Market Strength Events
Market strength indicators help investors to evaluate how Pharming Group pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharming Group shares will generate the highest return on investment. By undertsting and applying Pharming Group pink sheet market strength indicators, traders can identify Pharming Group NV entry and exit signals to maximize returns.
Pharming Group Risk Indicators
The analysis of Pharming Group's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharming Group's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharming pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.6435 | |||
| Standard Deviation | 2.28 | |||
| Variance | 5.2 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Pharming Pink Sheet
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Pink Sheet, refer to the following important reports:Check out Historical Fundamental Analysis of Pharming Group to cross-verify your projections. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.